We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$227M
AUM Growth
-$6.46M
Cap. Flow
-$15.1M
Cap. Flow %
-6.66%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HARP
1
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$66.9M 29.45%
452,443
TCRR
2
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$57.8M 25.46%
4,050,865
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$7.07B
$55M 24.19%
2,393,497
-681,396
-22% -$15.1M
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$28.5M 12.52%
5,736,296
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.84B
$19M 8.38%
2,168,691

Similar funds

MPM Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, MPM Asset Management held 5 positions worth $227M, down 2.8% from $234M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management withdrew a net $15.1M in Q4 2019, reducing 1 holding. Its largest reduction was Rhythm Pharmaceuticals, cutting an estimated $15.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q4 2019 reduction was Rhythm Pharmaceuticals, cutting an estimated $15.1M.
  • MPM Asset Management's ten largest holdings make up 100% of its $227M portfolio in Q4 2019.
  • MPM Asset Management opened 0 new positions and closed 0 in Q4 2019.
  • MPM Asset Management's portfolio value fell 2.8% quarter-over-quarter to $227M.

Based on MPM Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.